Gregory Wilding, PhD (Series Introduction) Professor Department of Biostatistics School of Public Health and Health Professions Director, CTSI BERD Core Michael LaMonte, PhD, MPH (Clinical Trials ...
Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...
The clinical trials market is ripe with opportunities due to rising chronic and rare diseases, advancements in precision ...
With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.
This workshop reviews the basics of Good Clinical Practice (GCP) and the recent updates that impact practice in an increasingly electronic environment. It will highlight the responsibilities the ...
A major international congress for the global pharmacology and therapeutics community, spanning both basic and clinical ...
Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...
News-Medical.Net on MSN
Analysis reveals why head and neck cancer clinical trials end early
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and ...
Join experts from Premier Research, Ashley Herrick, PhD, Vice President, Oncology Program Strategy; and Jordan Curry, Senior Project Director, Oncology, for the live webinar on Thursday, January 29, ...
Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...
This comprehensive program has been designed to be flexible and to meet the needs of the entire research team. Content is intended to address the competencies at various levels. The overall goal is to ...
The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results